Clinical Intestinal Transplantation: New Perspectives and Immunologic Considerations 1 1This study was supported in part by Project Grant No. DK 29661 from the National Institutes of Health, Bethesda, MD.
Kareem Abu‐Elmagd(University of Pittsburgh), Thomas E. Starzl(University of Pittsburgh Medical Center), Randall Lee(University of Pittsburgh), Jorge Rakela(University of Pittsburgh), Javier Bueno(University of Pittsburgh), Hiro Furukawa(Cold Spring Harbor Laboratory), William Irish(University of Pittsburgh Medical Center), Satoru Todo(Hokkaido University), Jorge Reyes(University of Pittsburgh), Ahmed Tarek I. Fawzy(University of Pittsburgh), Abdul S. Rao(University of Pittsburgh), John McMichael(University of Pittsburgh), John J. Fung(University of Pittsburgh), Noriko Murase(TCL (China)), Jake Demetris(University of Pittsburgh)
Cited by 264
Related Papers
Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document
|Hepatology|1997|1.3k
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
|The Lancet|1984|1.3k
Production of α1,3-Galactosyltransferase-Deficient Pigs
|Science|2003|1.1k
Evolution of Liver Transplantation
|Hepatology|1982|887
Clinical Pharmacokinetics of Tacrolimus
|Clinical Pharmacokinetics|1995|802